Cargando…

Shallominthe Active Antimicrobial Constituent of Persian Shallot in Treatment of Oral Herpes: A Double-Blind Randomized Clinical Trial

BACKGROUND: Previous studies showed that shallomin, the active antimicrobial constituent of Persian shallot, has a wide range of antibacterial and antifungal properties. OBJECTIVES: The objective of this randomized clinical trial was to evaluate the effectiveness of topical shallomin alcoholic solut...

Descripción completa

Detalles Bibliográficos
Autores principales: Pipelzadeh, Mohammad Hassan, Amin, Mansour, Shiravi Khozani, Abolfazl, Radmanesh, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: DOCS 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165175/
https://www.ncbi.nlm.nih.gov/pubmed/25237646
_version_ 1782335063536435200
author Pipelzadeh, Mohammad Hassan
Amin, Mansour
Shiravi Khozani, Abolfazl
Radmanesh, Mohammad
author_facet Pipelzadeh, Mohammad Hassan
Amin, Mansour
Shiravi Khozani, Abolfazl
Radmanesh, Mohammad
author_sort Pipelzadeh, Mohammad Hassan
collection PubMed
description BACKGROUND: Previous studies showed that shallomin, the active antimicrobial constituent of Persian shallot, has a wide range of antibacterial and antifungal properties. OBJECTIVES: The objective of this randomized clinical trial was to evaluate the effectiveness of topical shallomin alcoholic solution in treatment of cold sore. PATIENTS AND METHODS: A total of 60 volunteers who met the inclusion criteria were randomly allocated to two equal groups to hourly apply topical of either 0.5% shallomin alcoholic solution or placebo within the first 24 hours of developing cold sores. All the cases were reassessed at six-hour intervals. RESULTS: The cold sores were cleared within six hours among 30% of cases who received shallomin solution and the remaining of the cases in this group were cleared between 6six to 24 hours of application. In the placebo group, clearance of the sores occurred in four cases between 48 to 72 hours and the remaining of cases were cleared after 72 hours. CONCLUSIONS: The results of this study demonstrated that shallomin is a useful natural remedy in preventing the progression and treatment of cold sores and can significantly reduce the duration of ulceration.
format Online
Article
Text
id pubmed-4165175
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher DOCS
record_format MEDLINE/PubMed
spelling pubmed-41651752014-09-18 Shallominthe Active Antimicrobial Constituent of Persian Shallot in Treatment of Oral Herpes: A Double-Blind Randomized Clinical Trial Pipelzadeh, Mohammad Hassan Amin, Mansour Shiravi Khozani, Abolfazl Radmanesh, Mohammad Jundishapur J Nat Pharm Prod Research Article BACKGROUND: Previous studies showed that shallomin, the active antimicrobial constituent of Persian shallot, has a wide range of antibacterial and antifungal properties. OBJECTIVES: The objective of this randomized clinical trial was to evaluate the effectiveness of topical shallomin alcoholic solution in treatment of cold sore. PATIENTS AND METHODS: A total of 60 volunteers who met the inclusion criteria were randomly allocated to two equal groups to hourly apply topical of either 0.5% shallomin alcoholic solution or placebo within the first 24 hours of developing cold sores. All the cases were reassessed at six-hour intervals. RESULTS: The cold sores were cleared within six hours among 30% of cases who received shallomin solution and the remaining of the cases in this group were cleared between 6six to 24 hours of application. In the placebo group, clearance of the sores occurred in four cases between 48 to 72 hours and the remaining of cases were cleared after 72 hours. CONCLUSIONS: The results of this study demonstrated that shallomin is a useful natural remedy in preventing the progression and treatment of cold sores and can significantly reduce the duration of ulceration. DOCS 2014-08-01 /pmc/articles/PMC4165175/ /pubmed/25237646 Text en Copyright © 2014, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences; Published by DOCS. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Pipelzadeh, Mohammad Hassan
Amin, Mansour
Shiravi Khozani, Abolfazl
Radmanesh, Mohammad
Shallominthe Active Antimicrobial Constituent of Persian Shallot in Treatment of Oral Herpes: A Double-Blind Randomized Clinical Trial
title Shallominthe Active Antimicrobial Constituent of Persian Shallot in Treatment of Oral Herpes: A Double-Blind Randomized Clinical Trial
title_full Shallominthe Active Antimicrobial Constituent of Persian Shallot in Treatment of Oral Herpes: A Double-Blind Randomized Clinical Trial
title_fullStr Shallominthe Active Antimicrobial Constituent of Persian Shallot in Treatment of Oral Herpes: A Double-Blind Randomized Clinical Trial
title_full_unstemmed Shallominthe Active Antimicrobial Constituent of Persian Shallot in Treatment of Oral Herpes: A Double-Blind Randomized Clinical Trial
title_short Shallominthe Active Antimicrobial Constituent of Persian Shallot in Treatment of Oral Herpes: A Double-Blind Randomized Clinical Trial
title_sort shallominthe active antimicrobial constituent of persian shallot in treatment of oral herpes: a double-blind randomized clinical trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165175/
https://www.ncbi.nlm.nih.gov/pubmed/25237646
work_keys_str_mv AT pipelzadehmohammadhassan shallomintheactiveantimicrobialconstituentofpersianshallotintreatmentoforalherpesadoubleblindrandomizedclinicaltrial
AT aminmansour shallomintheactiveantimicrobialconstituentofpersianshallotintreatmentoforalherpesadoubleblindrandomizedclinicaltrial
AT shiravikhozaniabolfazl shallomintheactiveantimicrobialconstituentofpersianshallotintreatmentoforalherpesadoubleblindrandomizedclinicaltrial
AT radmaneshmohammad shallomintheactiveantimicrobialconstituentofpersianshallotintreatmentoforalherpesadoubleblindrandomizedclinicaltrial